Back to top
more

STERIS (STE)

(Delayed Data from NYSE)

$225.18 USD

225.18
487,798

+3.33 (1.50%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $225.18 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

4 Top Growth Picks as MedTech Battle Rages On

Trump's Obamacare replacement saga has made growth picks great opportunities for investors in MedTech sector.

    Civitas Solutions (CIVI) Q3 Earnings Beat, Revenues Miss

    Civitas Solutions (CIVI) gains on strength in Post-Acute Specialty Rehabilitation Services and Adult Day Health services in Q3. However, tweaked full-year 2017 guidance signals dull prospects.

      BioScrip (BIOS) Gains on CORE Initiatives, Competition Rife

      The company achieved annualized supply chain improvement since the acquisition of Home Solutions.

        Why Is STERIS (STE) Up 3.5% Since the Last Earnings Report?

        STERIS (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

          STERIS Continues to Trade Below Industry on Dull Outlook

          On Mar 16, we issued an updated research report on Ohio-based STERIS plc (STE).

            STERIS (STE) Up 3.1% Since Earnings Report: Can It Continue?

            STERIS (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

              STERIS (STE) Cuts 2017 View: Will it See Gloomy Days Ahead?

              On Feb 09, we issued an updated research report on Ohio-based STERIS plc (STE).

                Steris (STE) Q3 Dismal: Earnings Miss Estimates, View Cut

                Steris Plc (STE) reported third-quarter fiscal 2017 adjusted earnings per share (EPS) of 98 cents, in line with the year-ago quarter.

                  Mark Vickery headshot

                  Top Research Reports for December 29, 2016

                  Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo (WFC), Danaher (DHR) and Colgate-Palmolive (CL).

                    Steris Poor Q2 Disappoints, Synergy Health Raises Hope

                    On Dec 7, we issued an updated research report on OH-based STERIS plc (STE).

                      MedTech Tailwinds at a Glance: Which Stocks to Buy?

                      Positive demographic trends and new product innovation have been the vital force behind the continued uptrend of the sector???s performance.

                        Rush in Medical Device Investments: Should You Buy These Stocks?

                        Coming to the weakest links in the MedTech sector, we advise investors against names that offer little growth/opportunity in the near term.

                          Should You Buy Evolving Trends in Medical Devices?

                          Given the U.S. government's pushback on tax-dodging, we expected some sloth to creep into the medical device space as far as M&As are concerned. But to our surprise, M&A activity worldwide has remained fairly stable.

                            Brian Bolan headshot

                            3 Stocks For Buckeye Fans

                            Ohio State takes on Oregon for the college football national championship, but investors should take a look at Ohio based stocks